Preventing and Treating Tobacco and Nicotine Use in Pediatrics: A Clinical Support Chart

About Harold FarberMatthew Bars

Harold J. Farber MD MSPH FAAP is a Professor of Pediatrics Pulmonary Division at Baylor College of Medicine and Pediatric Pulmonologist at Texas Children's Hospital. His interests and accomplishments have focused on asthma muscular dystrophies tobacco dependence and tobacco control. Dr. Farber has served as lead or co-author for close to 100 articles in the peer reviewed scientific literature. He has authored chapters on asthma education and on tobacco dependence for allergy and for pulmonary textbooks. Dr. Farber has served as co-principal investigator for the Lowering Environmental Tobacco Smoke Exposure: LETS Manage Asthma study. He served as founding executive committee member and policy chair for the American Academy of Pediatrics Section on Tobacco Control (now the Section on Nicotine and Tobacco Prevention and Treatment) and as chair of the American Thoracic Society Tobacco Action Committee. He served as co-author for the American College of Chest Physicians Tobacco Dependence Toolkit and as co-chair for the American Thoracic Society Clinical Practice Guideline Initiating Pharmacologic Treatment in Tobacco Dependent Adults. Dr. Farber is a frequent speaker on tobacco control and tobacco dependence issues. He is interested in helping to ensure that tobacco dependence prevention and treatment is incorporated as a routine part of pediatric care. Outside of medicine Dr. Farbers interests include music travel and photography. His current musical interests include jazz and opera.Matthew Matt Bars is a master's-level psychologist and has been engaged in the treatment management and administration of nicotine addiction services for many years. Matt was the Clinical Director of the IQuit Smoking Program at RWJ Barnabas Health-Jersey City Medical Center Jersey City New Jersey and was appointed to their medical staff in 2011. He is also the co-developer and Clinical Director of the Tobacco Treatment Program of the New York City Fire Department (FDNY). The FDNY Tobacco Treatment Program enjoys a biochemically confirmed quit rate of ~70% at 10 year follow-up. Matt is also a former President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD). ATTUD is a non-profit organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user. Since December 2006 he has been retained by the American College of Chest Physicians as a principal author for their Tobacco Treatment Toolkit a training and consultation document and online resource for pulmonologists and other clinicians worldwide. In addition he helps physicians hospitals and medical centers establish sustainable and clinically successful tobacco treatment programs. In March 2013 Matt was appointed to the faculty of St. Georges School of Medicine Department of Psychiatry and he also serves on the editorial boards of the Journal of Smoking Cessation and the Journal of Medical Internet Research. Matt is the creator founder and Chief Quitting Officer of IntelliQuit.org and CustomQuit.com the world's first point-of-care cloud-based biochemical nicotine monitor for health care professionals and tobacco and nicotine dependent patients.